Buscar
Scienture Holdings Inc
SCNXAñadir a la lista de seguimiento
0.380USD
+0.013+3.49%
Cierre 07-28 16:00（ET）Cotizaciones retrasadas 15 min
15.44MCap. mercado
PérdidaP/E TTM
Más Datos de Scienture Holdings Inc Compañía
Scienture Holdings, Inc., through its wholly owned subsidiary, Scienture, LLC, is a specialty pharmaceutical company focused on providing enhanced value to patients, physicians and caregivers by offering specialty products to satisfy unmet market needs. Scienture, LLC is focused on developing and commercializing products for the treatment of central nervous system and cardiovascular diseases. Scienture LLC is developing a range of product candidates, including new potential treatments for hypertension, migraine, pain and thrombosis and other related disorders. The Company's product candidates include SCN- 102 (hypertension), SCN- 104 (CNS-Pain), SCN- 106 (Cardiovascular) and SCN- 107 (Pain). SCN-102 is an oral liquid formulation of losartan potassium in development for the treatment of hypertension. SCN-104 is a multi-dose pen-based delivery system for self-injection and increased patient convenience, which is in development for the acute treatment of migraine headaches.
Información de Scienture Holdings Inc
Símbolo de cotizaciónSCNX
Nombre de la empresaScienture Holdings Inc
Fecha de salida a bolsaFeb 18, 2020
Director ejecutivoHariharan (Shankar)
Número de empleados14
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 18
Dirección- -
Ciudad- -
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
País- -
Código postal- -
Teléfono- -
Sitio Web- -
Símbolo de cotizaciónSCNX
Fecha de salida a bolsaFeb 18, 2020
Director ejecutivoHariharan (Shankar)
Ejecutivos de Scienture Holdings Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Narasimhan Mani
Dr. Narasimhan Mani
President, Co-Chief Executive Officer, Director
President, Co-Chief Executive Officer, Director
1.05M
-132.91%
Mr. Subbarao Jayanthi
Mr. Subbarao Jayanthi
Independent Director
Independent Director
199.87K
--
Mr. Eric Sherb
Mr. Eric Sherb
Chief Financial Officer
Chief Financial Officer
50.00K
--
Mr. Donald G. Fell
Mr. Donald G. Fell
Independent Director
Independent Director
--
--
Mr. Mayur Doshi
Mr. Mayur Doshi
Independent Director
Independent Director
--
--
Dr. Shankar Hariharan, Ph.D.
Dr. Shankar Hariharan, Ph.D.
Executive Chairman of the Board, Co-Chief Executive Officer
Executive Chairman of the Board, Co-Chief Executive Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Narasimhan Mani
Dr. Narasimhan Mani
President, Co-Chief Executive Officer, Director
President, Co-Chief Executive Officer, Director
1.05M
-132.91%
Mr. Subbarao Jayanthi
Mr. Subbarao Jayanthi
Independent Director
Independent Director
199.87K
--
Mr. Eric Sherb
Mr. Eric Sherb
Chief Financial Officer
Chief Financial Officer
50.00K
--
Mr. Donald G. Fell
Mr. Donald G. Fell
Independent Director
Independent Director
--
--
Mr. Mayur Doshi
Mr. Mayur Doshi
Independent Director
Independent Director
--
--
Dr. Shankar Hariharan, Ph.D.
Dr. Shankar Hariharan, Ph.D.
Executive Chairman of the Board, Co-Chief Executive Officer
Executive Chairman of the Board, Co-Chief Executive Officer
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Scienture Holdings Inc?
Los cinco principales accionistas de Scienture Holdings Inc son: Dr. Narasimhan Mani
¿Cuántas instituciones poseen acciones de Scienture Holdings Inc (SCNX)?
A fecha de 2026Q1, 26 instituciones poseen acciones de Scienture Holdings Inc, con un valor de mercado combinado de aproximadamente 2.00M, lo que representa el 4.93% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 289959.00.